| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07188584 | Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in… | Nasopharyngeal Carcinoma (NPC) | Recruiting |
| NCT07328841 | Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally… | Nasopharyngeal Carcinoma (NPC) | Recruiting |
| NCT07328854 | 40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II… | Nasopharyngeal Carcinoma | Recruiting |
| NCT07481799 | Efficacy and Safety of SBRT Combined With Becotatug Vedotin (MRG003) in EGFR-Positive… | Oligo-metastatic Cancer | Recruiting |
| NCT07524452 | Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for… | Locally Advanced Head and Neck Squamous Cell Carcinoma | Recruiting |
| Phase 2 | |||
| NCT06472713 | Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in… | Recurrent or Metastatic Nasopharyngeal Carcinoma | Recruiting |
| NCT07070479 | Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma… | Recurrent or Metastatic Nasopharyngeal Carcinoma | Recruiting |
| NCT07581821 | Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic… | Recurrent or Metastatic Nasopharyngeal Carcinoma | Recruiting |
| Not specified | |||
| NCT06529562 | Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose… | Nasopharyngeal Carcinoma | Recruiting |
| NCT06688760 | Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed… | Nasopharyngeal Carcinoma | Recruiting |
| NCT06870435 | Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for… | Nasopharyngeal Carcinoma (NPC) | Recruiting |
| NCT06787456 | "Xijiang Project" Screening Cohort for NPC | Nasopharyngeal Carcinoma (NPC) | Active, Not Recruiting |